Transgenic commensals as mucosal protectants.
Whaley
K J
KJ
Zeitlin
L
L
D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000276:immunology / Q000627:therapeutic use; D002177:Candidiasis / Q000276:immunology / Q000382:microbiology / Q000628:therapy; D005260:Female; D006801:Humans; D007116:Immunization, Passive; D007130:Immunoglobulin Idiotypes / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology / Q000627:therapeutic use; D009092:Mucous Membrane / Q000276:immunology* / Q000382:microbiology* / Q000821:virology; D009183:Mycotoxins / Q000008:administration & dosage / Q000737:chemistry / Q000627:therapeutic use; D051381:Rats; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000276:immunology / Q000627:therapeutic use; D012749:Sexually Transmitted Diseases / Q000276:immunology / Q000382:microbiology / Q000628:therapy / Q000821:virology; D013291:Streptococcus / Q000235:genetics / Q000502:physiology*; D019076:Transgenes / Q000235:genetics*; D014621:Vagina / Q000166:cytology / Q000276:immunology / Q000382:microbiology
D000900:Anti-Bacterial Agents; D007130:Immunoglobulin Idiotypes; D009183:Mycotoxins; D011994:Recombinant Proteins